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INTRODUCTION:Weherein describe a rare case of a sclerosingmediastinitiswithout IgG4-related disease.
This case was clearly excluded from IgG4-related disease, because this patient’s serum IgG4 level was
not elevated. Speciﬁcally, this patient’s serum IgG4 level was 7.9mg/dl (4.8–105).
PRESENTATIONOFCASE:A61-year-old Japanese femalepresentedat ourhospital due to anabnormal chest
X-ray that showed a growing shadow in the mediastinum. Chest computed tomography (CT) showed an
80×75×75mm tumor, which located in the anterior mediastinum. This large tumor surrounded the
thoracic aorta, left brachiocephalic vein and superior vena cava. It was difﬁcult to obtain a deﬁnitive
diagnosis. We tried to perform three biopsies, and eventually performed a partial resection of the tumor.
DISCUSSION:This casedidnotﬁt the criteria for IgG4-relateddisease, and itwas thereforeunclearwhether
steroid therapy should be used for this case.Wewill continue to carefully follow up this patient’s residual
lesion, and there have been no changes in the lesion at present.
CONCLUSION: Sclerosing mediastinitis and IgG4-related disease should be included in the differential
diagnosis of patients presenting with a mediastinal tumor. However, sclerosing mediastinitis is difﬁcult
to diagnose, and it is important to obtain a sufﬁcient amount of tissue to ensure an accurate diagnosis.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Sclerosing mediastinitis was ﬁrst described by Oulmont in
1855, and was believed to be secondary to syphilis or tuberculosis
until 1925, when an association with fungal infections was pro-
posed by Knox [4]. Sclerosing mediastinitis, also called ﬁbrosing
mediastinitis, is a rare syndrome characterized by an aggressive
ﬁbroinﬂammatory process within the mediastinum [1,2]. Progres-
sive ﬁbrosis caused by the proliferation of invasive ﬁbrous tissue
within the mediastinum frequently results in compression and
functional compromise of vital mediastinal structures [2,3].
The precise etiology and pathogenesis of sclerosing mediastini-
tis remain unknown, despite extensive research. There has been a
suggested link to Histoplasma capsulatum (H. capsulatum) infection
in many North American cases. Because histopathological conﬁr-
mation is lacking in many cases, it has been proposed that the
link between H. capsulatum and sclerosing mediastinitis involves
an abnormal hypersensitivity reaction to H. capsulatum antigens,
rather thandirect infection of themediastinum [5]. Other etiologies
have also been cited, including other infections as well as autoim-
Abbreviations: CT, computed tomography; IgG4-RD, IgG4-related disease.
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mune and idiopathic ﬁbroinﬂammatory causes [5,6]. Recently, It is
said that sclerosing mediastinitis may be related to IgG4-related
disease (IgG4-RD). Some cases were reported to be examples of
IgG4-RD. By deﬁnition, IgG4-RD is currently considered to be an
idiopathic ﬁbroinﬂammatory disorder, which is characterized by
the expansion of IgG4-producing plasma cells. The triggers and
pathogenesis of IgG4-RD remain undeﬁned [9–13].
We experienced a case of sclerosing mediastinitis. This case
had diffuse noncalciﬁed involvement of the mediastinum, but this
patient did not have autoimmune or ﬁbroinﬂammatory disease
and infection disease. Furthermore, this patient’s serum IgG4 level
was not elevated. Speciﬁcally, this patient’s serum IgG4 level was
7.9mg/dl (4.8–105). Therefore, this case did not have IgG4-related
disease andwas not related to any of the infections previously sug-
gested to cause the condition. Consequently, this case may reveal
a new origin of sclerosing mediastinitis.
2. Presentation of Case
A 61-year-old Japanese female presented at our hospital due to
an abnormal chest X-ray that showed a growing shadow in the
mediastinum (Fig. 1A and B). Chest computed tomography (CT)
showed an 80×75×75mm tumor, which located in the anterior
mediastinum (Fig. 2A and B). This large tumor surrounded the tho-
racic aorta, left brachiocephalic vein and superior vena cava. The
patient had only a minor cough and had no remarkable past medi-
cal history. Her tumor marker levels were not elevated. Laboratory
http://dx.doi.org/10.1016/j.ijscr.2015.03.013
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. (A) and (B): Chest X-rays showing the growing mediastinal shadow from 2010(A) to 2012 years(B).
Fig. 2. (A) and (B): Chest computed tomography (CT) scans of the thorax showed an ill-deﬁned and inhomogenously enhanced inﬁltration at the anterior mediastinum.
tests, including a panel of antibodies for autoimmune processes,
an immunohistochemical analysis for lymphoma, fungal serology,
sputum smears and cultures for acid-fast bacilli, were all negative.
We initially tried to perform a core needle biopsy in the anterior
mediastinum. However, we could not obtain a deﬁnite diagnosis
based on this specimen. We next tried an open thoracic biopsy
whichwas performed from the left second intercostal space. At this
time, we got a specimen (15×15×15mm). However, no deﬁnite
diagnosis was possible from this specimen because this specimen
was inﬂammatory change. Finally, we performed a median ster-
notomy and tried to extirpate the tumor, but could not resect
the entire tumor because of its invasion into the superior vena
cava and right atrium. Therefore, we resected the left side of the
tumor and left brachiocephalic vein, which was replaced with an
artiﬁcial vessel (The 8mm diameter Gore-Tex expanded polyte-
traﬂuoroethylene graft).
The pathological diagnosis was sclerosing mediastinitis. The
ill-deﬁned tumorous lesion was composed of an overgrowth of
sclerosing hyalinized ﬁbrocollagenous bundles displaying irregular
fascicle or whorl-like structures with a predominant lymphoplas-
macytic inﬁltrate, admixed with a small number of eosinophils,
neutrophils and histiocytes, involving the adipose tissue and
medium-sized to large arteries in the anterior mediastinum. In the
peripheral areas, vasculitis with ﬁbrinoid necrosis and organizing
thrombosis was seen in themedium-sized vessels. In the immuno-
histochemical ﬁndings, there were very few IgG4-positive plasma
cells (Fig. 3A and B).
3. Discussion
It is difﬁcult to obtain a deﬁnitive diagnosis of sclerosing medi-
astinitis. It is indispensable to exclude other diseases, particularly
malignantdisease, in caseswith sclerosingmediastinitis. Therefore,
it is very important to obtain a sufﬁcient quantity of tumor tissue.
In the present case, we ﬁrst tried to do a core needle biopsy,
but could not diagnose the tumor. Then, we tried an open thoracic
biopsy,whichwasperformed fromthe left second intercostal space,
but were still unable to obtain a deﬁnite diagnosis. Third, we per-
formed a median sternotomy and tried to extirpate the tumor, but
could not resect the entire tumor because it had invaded the supe-
rior vena cava and right atrium. However, we were ﬁnally able to
obtain a deﬁnite diagnosis.
Fibrous diseases similar to sclerosing mediastinitis occur in
the pancreas, peritoneum, salivary gland, etc. [7–9]. Some cases
were reported to be examples of IgG4-related disease (IgG4-RD).
By deﬁnition, IgG4-RD is currently considered to be an idiopathic
ﬁbroinﬂammatory disorder, which is characterized by the expan-
sion of IgG4-producing plasma cells. The triggers and pathogenesis
of IgG4-RD remain undeﬁned. However, the disease is typically
responsive to glucocorticoid therapy [9–13]. Inoue et al. suggested
that the serum IgG4 level is a good selective indicator for steroid
therapy in patients with sclerosingmediastinitis [14]. Steroid ther-
apy may also be able to cure patients with sclerosing mediastinitis
with IgG4-RD.
CASE REPORT – OPEN ACCESS
S. Oka et al. / International Journal of Surgery Case Reports 10 (2015) 5–7 7
Fig. 3. (A) The ill-deﬁned tumorous lesions were composed of an overgrowth of sclerosing hyalinized ﬁbrocollagenous bundles displaying irregular fascicular or whorl-like
structures, with a predominant lymphoplasmacytic inﬁltrate, admixed with a small number of eosinophils, neutrophils and histiocytes, involving the adipose tissue and
medium-sized to large arteries in the anterior mediastinum. (B) In the immunohistochemical study, there were only a few IgG4-positive plasma cells, ruling out a diagnosis
of IgG4-RD.
However, the present case did not ﬁt the criteria for IgG4-
related disease, and the cause remains unknown. Therefore, it is
unknownwhether steroid therapy should be used for this case.We
will continue to carefully follow up this patient’s symptoms and
will regularly examine the tumor for changes. When a physician is
confronted with a patient who has a mediastinal tumor, it is nec-
essary to include sclerosing mediastinitis and IgG4-RD as potential
diagnoses.
4 Conclusion
Sclerosing mediastinitis and IgG4-RD should be included in the
differential diagnosis of patients presenting with a mediastinal
tumor. However, sclerosing mediastinitis is difﬁcult to diagnose,
and it is important to obtain a sufﬁcient amount of tissue to ensure
an accurate diagnosis.
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